These results suggest that elevated levels of MARCH7 aids in the progress of ovarian cancer, and promotes an aggressive behavior, indicating that MARCH7 may function as a novel tumor marker and a potential therapeutic target for ovarian cancer. The gene discussed is MARCHF7; the disease is ovarian carcinoma.